Also listed on Kleo Pharmaceuticals, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Nov 6, 2043 · High confidence
20-year base term ends Nov 18, 2040
Held by Biohaven Therapeutics Ltd.
Filed Apr 18, 2022 as application 17/769,924 · Granted Oct 27, 2026
Base term plus 1083 days of patent term adjustment (USPTO delay)
Today
2020
2043
Clock starts
Nov 18, 2020
Nov 18, 2020
Term ends
Nov 6, 2043
Nov 6, 2043
Granted
Oct 27, 2026
Oct 27, 2026
base term
patent term adjustment
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
1,083
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 1083 days past its 20-year base term on prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 18, 2020, when application PCT/US2020/061127, the earliest non-provisional in its chain, was filed (this one was filed Apr 18, 2022) | Nov 18, 2040 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +1083 days, USPTO patent term adjustment record | Nov 6, 2043 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Nov 6, 2043 | High confidence |
This family
| Application 62/937,131 | Provisional application no patent term | no patent term |
| Application 63/063,902 | Provisional application no patent term | no patent term |
| Application PCT/US2020/061127 | PCT application no patent term | no patent term |
| US 12,773,458 | this patent Nov 2043 | Nov 2043 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 17, 2026 Reel 75312, frame 56 | Kleo Pharmaceuticals, Inc. | Biohaven Therapeutics Ltd. | Assignment of Assignor's Interest |
| Jul 17, 2026 Reel 75312, frame 133 | Spiegel, David Adam | Yale University | Assignment of Assignor's Interest |
| Jul 17, 2026 Reel 75312, frame 215 | Vaill, Ada Margaret; Bunin, Anna; Vidal, Christian Marcel; Alvarez, Enrique | Kleo Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Jul 17, 2026 Reel 75312, frame 317 | Berbasova, Tetyana; Cukan, Michael C.; Iben, Lawrence Gerald | Kleo Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Jul 17, 2026 Reel 75312, frame 323 | Rastelli, Luca | Kleo Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Jul 17, 2026 Reel 75312, frame 352 | Welsch, Matthew | Kleo Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Jul 17, 2026 Reel 75998, frame 944 | Sixth Street Specialty Lending, Inc. | Biohaven Pharmaceutical Holding Company Ltd.; Biohaven Therapeutics Ltd.; Biohaven Pharmaceutical Ireland Designated Activity Company | Release of Security Interest |
| Jul 17, 2026 reel/frame not recorded | Sixth Street Specialty Lending, Inc. | Biohaven Pharmaceutical Holding Company Ltd. | Release of Security Interest |
| Jul 17, 2026 reel/frame not recorded | Sixth Street Specialty Lending, Inc. | Biohaven Therapeutics Ltd. | Release of Security Interest |
| Jul 17, 2026 reel/frame not recorded | Sixth Street Specialty Lending, Inc. | Biohaven Pharmaceutical Ireland Designated Activity Company | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Nov 2043
Term ends Nov 6, 2043. Maintenance fees still fall due before then
Note
The 1083 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
We have no citation count for this patent yet. That is not the same as never having been cited.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.